-
A Clinical Study of Intismeran Autogene (V940) and Pembrolizumab (MK-3475) in People With Melanoma (V940-012/INTerpath-012)
NCT06961006 ·
Phase: Phase 2 ·
Ages: 18 Years and older ·
Sex: All (male and female)
· New Jersey: Hackensack
-
A Phase 1 Study of PLN-101095 in Adults With Advanced or Metastatic Solid Tumors
NCT06270706 ·
Phase: Phase 1 ·
Ages: 18 Years and older ·
Sex: All (male and female)
· New Jersey: East Brunswick
-
A Study Assessing KB707 for the Treatment of Locally Advanced or Metastatic Solid Tumors
NCT05970497 ·
Phase: Phase 1, Phase 2 ·
Ages: 18 Years and older ·
Sex: All (male and female)
· New Jersey: Morristown
-
A Study Evaluating the Integrative Medicine at Home (IM@HOME) Program in People With Cancer
NCT05053230 ·
Phase: Not applicable (e.g. observational or device study) ·
Ages: 18 Years and older ·
Sex: All (male and female)
· New Jersey: Basking Ridge, Middletown, Montvale
-
A Study With Combinations of Anti-LAG-3 and Anti-PD-1 Antibodies in Adult Participants With Advanced or Metastatic Melanoma (Harmony Head-to-Head)
NCT06246916 ·
Phase: Phase 3 ·
Ages: 18 Years and older ·
Sex: All (male and female)
· New Jersey: Hackensack, New Brunswick, Paramus
-
A Study of 68Gallium PSMA-PET/CT Scans in People With Bladder Cancer or Skin Cancer
NCT05562791 ·
Phase: Phase 1 ·
Ages: 18 Years and older ·
Sex: All (male and female)
· New Jersey: Basking Ridge, Middletown, Montvale
-
A Study of BMS-986340 as Monotherapy and as Combination Therapy in Participants With Advanced Solid Tumors
NCT04895709 ·
Phase: Phase 1, Phase 2 ·
Ages: 18 Years and older ·
Sex: All (male and female)
· New Jersey: Hackensack
-
A Study of Fianlimab, Cemiplimab, and Ipilimumab in People With Melanoma
NCT06594991 ·
Phase: Phase 2 ·
Ages: 18 Years and older ·
Sex: All (male and female)
· New Jersey: Basking Ridge, Hackensack, Middletown, Montvale
-
A Study of MQ710 With and Without Pembrolizumab in People With Solid Tumor Cancer
NCT05859074 ·
Phase: Phase 1 ·
Ages: 18 Years and older ·
Sex: All (male and female)
· New Jersey: Basking Ridge, Middletown, Montvale
-
A Study of Radiation Therapy to Treat Solid Tumor Cancer That Has Spread to Soft Tissue
NCT05837767 ·
Phase: Not applicable (e.g. observational or device study) ·
Ages: 18 Years and older ·
Sex: All (male and female)
· New Jersey: Basking Ridge, Middletown, Montvale
-
A Study to Evaluate KIN-2787 in Participants With BRAF and/or NRAS Mutation Positive Solid Tumors
NCT04913285 ·
Phase: Phase 1 ·
Ages: 18 Years and older ·
Sex: All (male and female)
· New Jersey: Morristown, New Brunswick
-
A Study to Learn About the Study Medicine Called PF-07799544 as Monotherapy or in Combination in People With Advanced Solid Tumors
NCT05538130 ·
Phase: Phase 1 ·
Ages: 16 Years and older ·
Sex: All (male and female)
· New Jersey: Basking Ridge, Middletown, Montvale
-
A Study to Learn About the Study Medicine Called PF-07799933 in People With Advanced Solid Tumors With BRAF Alterations.
NCT05355701 ·
Phase: Phase 1 ·
Ages: 16 Years and older ·
Sex: All (male and female)
· New Jersey: Middletown
-
Assessing Benefits and Harms of Cannabis/Cannabinoid Use Among Cancer Patients Treated in Community Oncology Clinics
NCT06418204 ·
Phase: Not specified ·
Ages: 18 Years and older ·
Sex: All (male and female)
· New Jersey: Englewood, Freehold, Hackettstown, Morristown
-
Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection
NCT05334069 ·
Phase: Not specified ·
Ages: 40 Years to 75 Years ·
Sex: All (male and female)
· New Jersey: Englewood, Freehold, Hackettstown, Morristown
-
DOC1021 Dendritic Cell Immunotherapy for Refractory Melanoma
NCT07288112 ·
Phase: Phase 1, Phase 2 ·
Ages: 18 Years and older ·
Sex: All (male and female)
· New Jersey: Morristown
-
Efficacy of Daromun Neoadjuvant Intratumoral Treatment in Clinical Stage IIIB/C/D Melanoma Patients
NCT03567889 ·
Phase: Phase 3 ·
Ages: 18 Years and older ·
Sex: All (male and female)
· New Jersey: New Brunswick
-
IMC-F106C Regimen Versus Nivolumab Regimens in Previously Untreated Advanced Melanoma (PRISM-MEL-301)
NCT06112314 ·
Phase: Phase 3 ·
Ages: 18 Years and older ·
Sex: All (male and female)
· New Jersey: Hackensack
-
Melanoma Margins Trial-II: 1cm v 2cm Wide Surgical Excision Margins for AJCC Stage II Primary Cutaneous Melanoma
NCT03860883 ·
Phase: Not applicable (e.g. observational or device study) ·
Ages: 18 Years and older ·
Sex: All (male and female)
· New Jersey: Livingston, Piscataway
-
MySmartSkin Online Skin Self-exam Intervention for Melanoma Survivors
NCT05373823 ·
Phase: Not applicable (e.g. observational or device study) ·
Ages: 18 Years and older ·
Sex: All (male and female)
· New Jersey: New Brunswick
-
Naltrexone and Propranolol Combined With Immunotherapy
NCT05968690 ·
Phase: Phase 1 ·
Ages: 18 Years and older ·
Sex: All (male and female)
· New Jersey: New Brunswick
-
Nodal Radiation Therapy for Sentinel Lymph Node Positive Melanoma
NCT04594187 ·
Phase: Phase 2 ·
Ages: 18 Years and older ·
Sex: All (male and female)
· New Jersey: Camden
-
ORACLE: Observation of ResiduAl Cancer With Liquid Biopsy Evaluation
NCT05059444 ·
Phase: Not specified ·
Ages: 18 Years and older ·
Sex: All (male and female)
· New Jersey: East Brunswick
-
Project: Every Child for Younger Patients With Cancer
NCT02402244 ·
Phase: Not specified ·
Ages: Up to 25 Years ·
Sex: All (male and female)
· New Jersey: Hackensack, Morristown, Neptune City, New Brunswick
-
RAPA-201 Therapy of Solid Tumors
NCT05144698 ·
Phase: Phase 1, Phase 2 ·
Ages: 18 Years and older ·
Sex: All (male and female)
· New Jersey: Hackensack
-
SUPRAME-ACTengine® IMA203 vs. Investigator's Choice of Treatment in Previously Treated, Unresectable or Metastatic Cutaneous Melanoma
NCT06743126 ·
Phase: Phase 3 ·
Ages: 18 Years and older ·
Sex: All (male and female)
· New Jersey: Morristown
-
SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
NCT03452774 ·
Phase: Not specified ·
Ages: No age limits stated ·
Sex: All (male and female)
· New Jersey: New Brunswick
-
Study of AU-007, A Monoclonal Antibody That Binds to IL-2 and Inhibits IL-2Rα Binding, in Patients With Unresectable Locally Advanced or Metastatic Cancer
NCT05267626 ·
Phase: Phase 1, Phase 2 ·
Ages: 18 Years and older ·
Sex: All (male and female)
· New Jersey: Morristown
-
Study of Intralesional Cemiplimab in Adult Patients With Early Stage Cutaneous Squamous Cell Carcinoma
NCT06585410 ·
Phase: Phase 3 ·
Ages: 18 Years and older ·
Sex: All (male and female)
· New Jersey: Clark
-
Study to Investigate Lifileucel Regimen Plus Pembrolizumab Compared With Pembrolizumab Alone in Participants With Untreated Advanced Melanoma.
NCT05727904 ·
Phase: Phase 3 ·
Ages: 18 Years to 70 Years ·
Sex: All (male and female)
· New Jersey: Camden
-
TTX-080 HLA-G Antagonist in Subjects With Advanced Cancers
NCT04485013 ·
Phase: Phase 1 ·
Ages: 18 Years and older ·
Sex: All (male and female)
· New Jersey: New Brunswick
-
Tebentafusp Regimen Versus Investigator's Choice in Previously Treated Advanced Melanoma (TEBE-AM)
NCT05549297 ·
Phase: Phase 3 ·
Ages: 18 Years and older ·
Sex: All (male and female)
· New Jersey: New Brunswick
-
Testing Longer Duration Radiation Therapy Versus the Usual Radiation Therapy in Patients With Cancer That Has Spread to the Brain
NCT06500455 ·
Phase: Phase 3 ·
Ages: 18 Years and older ·
Sex: All (male and female)
· New Jersey: Basking Ridge, Cherry Hill, Livingston, Middletown
-
VO and Nivolumab vs Physician's Choice in Advanced Melanoma That Progressed on Anti-PD-1 & Anti-CTLA-4 Drugs [IGNYTE-3]
NCT06264180 ·
Phase: Phase 3 ·
Ages: 12 Years and older ·
Sex: All (male and female)
· New Jersey: Camden, Hackensack, Morristown